Coramaze Technologies
PrivateLast Round
Grant
Mar 17, 2026
Total Funding Raised
$6.51M
Company Overview
Coramaze Technologies operates in Healthcare & Life Sciences and is based in Bonn. Its latest recorded funding round was a Series A round in September 2015.
Coramaze Technologies is a medical technology company that develops Tripair, a minimally invasive transcatheter solution for treating tricuspid regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Coramaze Technologies Comparables
Compare Coramaze Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CroíValve | 92% | |
| Mitralix Ltd. | 88% | |
| TriFlo Cardiovascular Inc. | 87% |
For institutional investors. Book with your work email.
Coramaze Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 17, 2026 | ||||
| Series A | Sep 1, 2015 | ||||
| Seed | Feb 12, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Coramaze Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| SeedCapital Dortmund | Series A, Seed |
| High-Tech Gründerfonds | Series A, Seed |
| Elron Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2025
Grew 16% QoQ, from 19 to 22 employees.
- Aug 24, 2024
Grew 19% QoQ, from 16 to 19 employees.
For institutional investors. Book with your work email.
Coramaze Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Coramaze Technologies's valuation, stock price, and market status.
Is Coramaze Technologies a public or private company?
Coramaze Technologies is a private company.
What is the current stock price of Coramaze Technologies?
Coramaze Technologies is a private company, so its shares have no public market price. Caplight tracks Coramaze Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Coramaze Technologies worth (valuation)?
Valuation information for Coramaze Technologies is not publicly available.
Can I buy Coramaze Technologies stock?
Coramaze Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Coramaze Technologies's last funding round?
Coramaze Technologies's most recent funding round was Grant on March 17, 2026.
Who are the main investors in Coramaze Technologies?
Key investors in Coramaze Technologies include European Innovation Council Fund, SeedCapital Dortmund, High-Tech Gründerfonds, Elron Ventures.
Will Coramaze Technologies IPO soon?
No public IPO plans have been announced for Coramaze Technologies.
How can I track Coramaze Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Coramaze Technologies's shares on secondary markets.